European Medicines Agency validates marketing application for Filgotinib for the treatment of rheumatoid arthritis

This article was originally published here

“We are excited about the validation of this application which is an important milestone in our ongoing work to improve the lives of people living with rheumatoid arthritis

The post European Medicines Agency validates marketing application for Filgotinib for the treatment of rheumatoid arthritis appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply